Investor Endurant Capital Management LP
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Endurant Capital Management LP . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2024-10-30 13D/A US461203AH42 / Invacare Corp Bond 41,150,068 2,986,528
2024-04-10 13D/A US461203AH42 / Invacare Corp Bond 41,150,068
2023-09-08 13D/A IVC / Invacare Corp. 2,986,092 39,488,569
2023-05-15 13D IVC / Invacare Corp. 2,986,092
2023-03-21 13G/A ELUT / Elutia Inc. 1,259,544 576,253
2023-02-14 13G/A ELUT / Elutia Inc. 1,075,640 1,259,544
2023-02-14 13G/A ELUT / Elutia Inc. 1,075,640 1,259,544
2022-02-14 13G/A AZYO / Aziyo Biologics Inc - Class A 873,159 1,075,640
2021-06-09 13G AZYO / Aziyo Biologics Inc - Class A 873,159
2021-02-17 13G/A / Oxford Immunotec Global PLC 2,240,421 0
2021-02-12 13G / Oxford Immunotec Global PLC 2,240,421